News
Medytox Holds 2026 Global Anatomy Workshop in Bangkok
Medytox signs botulinum toxin distribution agreement worth USD 73 million with Blau Farmacêutica, from Brazil
Medytox’s Sweeping Victory in Botulinum Toxin Suit against Daewoong
The United States International Trade Commission (ITC) decided to institute an investigation into unlawful acts against Hugel, Inc., Hugel America, Inc., and Croma Pharma GmbH
Medytox retained a world-class law firm ‘Quinn Emanuel Urquhart & Sullivan, LLP’… to pursue its legitimate rights to the company’s intellectual property
Medytox signs a settlement agreement with AEON Biopharma… U.S. litigations are concluded
Medytox, Allergan, and Evolus announce settlement of intellectual property litigation
The full text of the final determination by the U.S. International Trade Commission is released, ‘Daewoong acquired Medytox’s strain by improper means’
The US ITC’s Administrative Law Judge found Daewoong Pharmaceutical misappropriated Medytox’s strain…Recommended that the import of 'Nabota' be banned for 10 years